Key result
Intracoronary aspirin reduces peak reactive hyperemia flow ~18% in preclinical models.
Why the study?
The effects of intracoronary aspirin on coronary blood flow and reactive hyperemia were not fully characterized in a controlled experimental setting.
Does intracoronary aspirin reduce coronary blood flow and reactive hyperemia in a canine model?
Does intracoronary aspirin reduce coronary blood flow and reactive hyperemia in a canine model?
Intracoronary aspirin increases coronary arterial resistance and restricts maximal dilating capacity in a canine model, likely via inhibition of prostacyclin synthesis.
Answers are grounded in this paper and cite their sources.
May warrant caution with intracoronary aspirin; leaves open effects on human coronary reactivity.
Effects of intracoronary aspirin on coronary blood flow and reactive hyperemia were evaluated in closed-chest, anesthetized dogs. In 18 dogs the left circumflex coronary artery was cannulated and perfused by arterial blood at a constant pressure. Coronary blood flow was measured by an electromagnetic flowmeter. Intracoronary aspirin at doses of 5, 10, and 20 mg reduced coronary blood flow in a dose-dependent manner. Injection of aspirin at doses of 10 to 25 mg also inhibited reactive hyperemia following the coronary occlusion for fifteen seconds. The mean peak flow ratio was reduced from 2.13 +/- 0.42 to 1.75 +/- 0.35 (p less than 0.005). The increment of coronary blood flow provoked by intracoronary arachidonic acid at doses of 150 to 300 micrograms was almost entirely inhibited by the pretreatment of the coronary artery with aspirin. The authors conclude that aspirin increases coronary arterial resistance in a dose-dependent manner and also restricts the maximal dilating capacity, possibly by inhibition of prostacyclin synthesis.
No takes yet. Share an insight, caveat, or question.
Miyajima et al. (1989) studied this question. Intracoronary aspirin vs. Baseline/Control was evaluated on Mean peak flow ratio (reactive hyperemia following 15-second coronary occlusion) (p=<0.005). Intracoronary aspirin reduced the mean peak flow ratio of reactive hyperemia from 2.13 to 1.75 in anesthetized dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: